Using artificial intelligence to learn optimal regimen plan for Alzheimer’s disease is a research paper published in Journal of the American Medical Informatics Association (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS
Grant: R00GM135488
National Institutes of Health
Grant: U01 AG024904
Department of Defense
Grant: W81XWH-12-2-0012
National Institute of Biomedical Imaging and Bioengineering
Grant: AbbVie
NIGMS NIH HHS
Grant: K99 GM135488
Alzheimer’s Drug Discovery Foundation
Araclon Biotech
CereSpir, Inc.
Janssen Alzheimer Immunotherapy Research & Development, LLC
National Institute on Aging
Alzheimer’s Disease Neuroimaging Initiative
EuroImmun; F. Hoffmann-La Roche Ltd
National Institutes of Health
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
The Canadian Institutes of Health Research
Alzheimer’s Association
BioClinica, Inc.
National Institute of Health
Bristol-Myers Squibb Company
FWCI
1.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords